Stem cell specialists face questioning

A top panel of experts will face questions of public and scientific concern on stem cell research during an international conference being held at The University of Manchester this week.

The Stem Cell Question Time will be headed by Lord Naren Patel, chair of the UK National Stem Cell Network, as part of Stem Cell Manchester, a three-day gathering of stem cell researchers from across the globe.

Among the panellists at Wednesday’s event will be Ron McKay from the National Institutes of Health, Bethesda, USA, Justine Burley, from the University of Singapore, and Jed Davies, from the University of Toronto, Canada.

The audience, which will be comprised of scientists both within and outside the field, will be invited to submit questions on important, contentious and challenging issues facing the stem cell research community.

Such topics up for discussion are likely to focus on the ethical issues surrounding stem cell research as well as the scientific challenges that must be overcome if this cutting-edge branch of biomedical research is to fulfil its true potential.

Also on the panel are Alan Coleman, from Embryonic Stem Cell International, Singapore, Chris Mason, from University College, London, and Daniel Brison, Co-director of the Northwest Embryonic Stem Cell Research Centre based at St Mary’s Hospital and The University of Manchester.

“The Stem Cell Manchester conference has attracted leading figures in stem cell research from across the world,” said organiser Professor Tim Hardingham, who is based in Manchester’s Faculty of Life Sciences.

“We have a packed programme of speakers lined up over the next few days culminating with the Question Time event on Wednesday where people outside the field can take part in a full and frank debate of the issues surrounding stem cell research.”

Among the speakers at the conference is Shinya Yamanaka, whose team at Kyoto University in Japan is pioneering ways of producing stem cells from adult human cells and therefore avoiding the need for embryos.

Source: University of Manchester

Related stories:

A breakthrough, then a surge, in stem cell research
Less than a year after a Wisconsin team helped discover a major alternative to human embryonic stem cells, the Madison scientists say more than 800 labs have begun using the approach, suggesting that many stem-cell researchers are starting to move beyond controversial embryonic sources for their work.
Response to immune protein determines pathology of multiple sclerosis
New research may help reveal why different parts of the brain can come under attack in patients with multiple sclerosis (MS). According to a new study in mice with an MS-like disease, the brain's response to a protein produced by invading T cells dictates whether it's the spinal cord or cerebellum that comes under fire. The study—from researchers at the University of Maryland School of Medicine in Baltimore and Washington University in St. Louis—will be published online on October 13th in the Journal of Experimental Medicine.
Landmark study unlocks stem cell, DNA secrets to speed therapies
In a groundbreaking study led by an eminent molecular biologist at Florida State University, researchers have discovered that as embryonic stem cells turn into different cell types, there are dramatic corresponding changes to the order in which DNA is replicated and reorganized.
Fat-regenerating 'stem cells' found in mice
Researchers have identified stem cells with the capacity to build fat, according to a report in the October 17th issue of the journal Cell, a Cell Press publication. Although they have yet to show that the cells can renew themselves, transplants of the progenitor cells isolated from the fat tissue of normal mice can restore normal fat tissue in animals that are otherwise lacking it.
Researcher eliminates viral vector in stem cell reprogramming
Shinya Yamanaka MD, PhD, of Kyoto University and the Gladstone Institute of Cardiovascular Disease (GICD) has taken another step forward in improving the possibilities for the practical application of induced pluripotent stem (iPS) cell technology.
Scientists pinpoint key proteins in blood stem cell replication
A family of cancer-fighting molecules helps blood stem cells in mice decide when and how to divide, say researchers at the Stanford University School of Medicine. Blocking the molecules' function spurs the normally resting cells to begin proliferating strangely - making too much of one kind of cell and not enough of another. Many types of human blood cancers involve a similar disruption in the expression of that same family of molecules.
University: Stem-cell study used falsified data
(AP) -- The University of Minnesota has concluded that falsified data were used in a 2001 article published by one of its researchers on adult stem cells. The school is asking that the article be retracted.
Scientists identify a molecule that coordinates the movement of cells
Even cells commute. To get from their birthplace to their work site, they sequentially attach to and detach from an elaborate track of exceptionally strong proteins known as the extracellular matrix. Now, in research to appear in the October 3 issue of Cell, scientists at the Howard Hughes Medical Institute and Rockefeller University show that a molecule, called ACF7, helps regulate and power this movement from the inside - findings that could have implications for understanding how cancer cells metastasize.

News discussion:

Medicine & Health news